Synthesis of Solanum Glycosides

Information

  • Patent Application
  • 20080039628
  • Publication Number
    20080039628
  • Date Filed
    April 30, 2004
    20 years ago
  • Date Published
    February 14, 2008
    16 years ago
Abstract
The present invention relates to the chemical synthesis of solanum glycosides, in particular to the synthesis of solasonine as well as to novel β-monosaccharide intermediate compounds, of Formula (II), where each R1 is the same or different and independently represents a benzylidene, 4-nitrobenzylidene or 4-methoxybenzylidene group and each R2 is the same or different and independently represents a benzoyl, acetyl or pivaloyl group.
Description
DETAILED DESCRIPTION OF THE INVENTION

It was unexpectedly found that by reacting a D-galacto-pyranosyl donor of the following formula 1







wherein each R1 is the same or different and independently represents a benzylidene, 4-nitrobenzylidene or 4-methoxybenzylidene group


each R2 is the same or different and independently represents a benzoyl, acetyl or pivaloyl group and


R3 is halogen, SPh or SEt

with solasodine the correspondingly protected β-glycoside of formula 2 could be obtained in high yield.







wherein each R1 is the same or different and independently represents a benzylidene, 4-nitrobenzylidene or 4-methoxybenzylidene group and each R2 is the same or different and independently represents a benzoyl, acetyl or pivaloyl group.


Preferably the reaction is carried out in the presence of a promoter.


Any conventional promoter as used in carbohydrate chemistry may be used.


The following promoters are particularly preferred:


Silver triflate, boron trifluoride diethyl etherate (−10° C.), trimethylsilyl triflate bromide, N-iodosuccinimide, thiomethyl sulfonium triflate.


The reaction is preferably carried out using dichloromethane as the solvent. Preferably the reaction time is 30 min.-1 hr.


The desired end product solasonine may be prepared by partially deprotecting the β-glycoside of formula 2 to give intermediate formula 3(1) and then selectively silylating one of the hydroxyl groups (OH-2 and OH-3) using tert-butyldimethylsilyl chloride, imidazole in DMF at 50° C.


However, due to the small selectivity between the OH-2 and OH-3 hydroxyl groups a mixture of OH-2 and OH-3 silylated protected β-glycosides are formed. The OH-3 silylated protected β-glycoside can mostly be precipitated from the mixture in methanol of the formula 3(2).







wherein each of R1 is the same or different and represent independently from each other benzylidene, 4-nitrobenzylidene or 4-methoxybenzylidene,


R2 is tert-butylsilyl or H and R3 is H.

The OH-3 protected galactose-solasodine adduct is then glycosylated at the OH-2 with a suitable α-L-rhamnopyranosyl donor.


Suitable rhamnose donors include tri-O-benzolyl-α-rhamnopyranosly, tri-O-pivoloyl-L-rhamnopyranosyl, or tri-O-acetyl-4-L-rhamnopyranosyl bromides of formula 4







wherein each of R1 is the same or different and independently represents acetyl, benzoyl or pivaloyl,


and R2 is halogen or SEt, SPh


Deprotection of the tert-butylsilyl group at the OH-3 position using tetrabutylammonium flouride in THF and glycosidation with a suitable α-D-glucopyranosly donor,


wherein the D-gluco-pyranosyl donor is tetra-O-benzoyl-α-D-glucopyranosyl bromide, tetra-O-acetyl-α-D-glucopyranosyl bromide or tetra-O-pivoloyl-α-D-glucopyranosyl bromide, or a thio-glycoside of the general formula 5







wherein each of R1 is the same or different an independently represents acetyl, benzoyl or pivaloyl and R2 is halogen, SEt, SPh gives a fully protected solasonine of formula 6(1).







wherein each R1 is the same or different and independently represents benzylidene, 4-nitrobenzyilidene or 4-methoxybenzylidene and each R2 are the same or different and independently represent acetyl, benzoyl or pivaloyl.


The protected solasonine formula 6(1) may be de-acetalised using aqueous acetic acid at 70° C. and de-esterified using sodium methoxide in methanol/dichloromethane mixture to give the fully deprotected solasonine formula 6(2) where in R1 and R2 are H.

Claims
  • 1. A galactose-solasodine conjugate of the general formula 2 or a derivative thereof
  • 2. A method for the preparation of the galactose-solasodine conjugate as defined in claim 1, comprising the reaction of solasodine with a galactopyranosyl donor of general formula 1
  • 3. A method for the preparation of solasonine comprising the silylation of the diol of formula 3(1) to give a selectively silylated product in the OH-3 position 3(2)
  • 4. The method according to claim 3, wherein the D-gluco-pyranosyl donor is tetra-O-benzoyl-α-D-glucopyranosyl bromide, tetra-O-acetyl-α-D-glucopyranosyl bromide or tetra-O-pivoloyl-α-D-glucopyranosyl bromide.
  • 5. The method according to claim 2-4, wherein the glycosylation reaction is carried out in the presence of a promoter selected from silver triflate, boron trifluoride diethyl etherate, trimethylsilyl triflate bromide, N-iodosuccinimide or dimethyl thiomethyl sulfonium triflate.
  • 6. The method of claim 3, wherein the protected glycoside is deprotected in methanol-dichloromethane solution by treatment with sodium methoxide, followed by neutralization with a mild acid ion-exchange resin.
  • 7. The method of claim 3-6, wherein the hydroxyl groups (OH-4 and OH-6) are protected by acetalisation with Benzaldehyde dimethoxy acetal in DMF and a catalytic amount of para-toluene sulphonic acid.
  • 8. The method of claim 3-7, wherein the rhamnose donor is tri-O-benzoyl-α-L-rhamnopyranosyl bromide, or a thio-glycoside of the general formula 4
  • 9. The method of claim 3-8, wherein the glucose donor is tetra-O-benzoyl-α-D-glucopyranosyl bromide, or a thio-glycoside of the general formula 5
  • 10. The method of claim 3-9, wherein the protected solasonine is de-acetalised and de-esterified by treatment with 80% acetic and then sodium methoxide solution in methanol-dichloromethane, followed by neutralization mild acid ion-exchange resin.
Priority Claims (1)
Number Date Country Kind
03009725.7 Apr 2003 EP regional
PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/EP04/04629 4/30/2004 WO 00 4/10/2007